Assessing the Impact of New Therapies on Hemophilia Patients

Time: 9:00 am
day: Day One

Details:

  • Understanding patient preferences in the HAVEN trials
  • Evaluating surgical outcomes within emicizumab trials
  • Clarifying the role of new therapies in inhibitor patients

Speakers: